Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 885.00
0.00 (0.00%)
Aug 6, 2026, 9:00 AM JST
Kohjin Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 332 | 1,015 | 635 | - | - |
Depreciation & Amortization | 396 | 360 | 299 | - | - |
Loss (Gain) From Sale of Assets | 10 | -1 | - | - | - |
Loss (Gain) From Sale of Investments | 9 | - | - | - | - |
Loss (Gain) on Equity Investments | -33 | -98 | -71 | - | - |
Other Operating Activities | -183 | -202 | -474 | - | - |
Change in Accounts Receivable | 306 | -27 | -94 | - | - |
Change in Inventory | 16 | -188 | 424 | - | - |
Change in Accounts Payable | -102 | -23 | 95 | - | - |
Change in Other Net Operating Assets | -53 | 79 | 9 | - | - |
Operating Cash Flow | 698 | 915 | 823 | - | - |
Operating Cash Flow Growth | -23.72% | 11.18% | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -970 | -862 | -562 | - | - |
Sale of Property, Plant & Equipment | -9 | 2 | - | - | - |
Sale (Purchase) of Intangibles | - | -25 | - | - | - |
Investment in Securities | 101 | -200 | - | - | - |
Other Investing Activities | 11 | -5 | -15 | - | - |
Investing Cash Flow | -867 | -1,090 | -577 | - | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 800 | 1,300 | 600 | - | - |
Long-Term Debt Issued | - | - | 750 | - | - |
Total Debt Issued | 800 | 1,300 | 1,350 | - | - |
Short-Term Debt Repaid | -800 | -1,300 | -300 | - | - |
Long-Term Debt Repaid | -150 | -150 | -939 | - | - |
Total Debt Repaid | -950 | -1,450 | -1,239 | - | - |
Net Debt Issued (Repaid) | -150 | -150 | 111 | - | - |
Issuance of Common Stock | - | 1,653 | - | - | - |
Common Dividends Paid | -122 | -58 | -79 | - | - |
Other Financing Activities | -48 | -69 | -33 | - | - |
Financing Cash Flow | -320 | 1,376 | -1 | - | - |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 26 | 21 | 19 | - | - |
Net Cash Flow | -463 | 1,222 | 264 | - | - |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -272 | 53 | 261 | - | - |
Free Cash Flow Growth | - | -79.69% | - | - | - |
Free Cash Flow Margin | -5.51% | 1.02% | 5.47% | - | - |
Free Cash Flow Per Share | -53.21 | 10.51 | 62.66 | - | - |
Levered Free Cash Flow | -369 | -70.38 | 188.38 | - | - |
Unlevered Free Cash Flow | -345.25 | -51.63 | 202.13 | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 38 | 29 | 23 | - | - |
Cash Income Tax Paid | 227 | 201 | 475 | - | - |
Change in Working Capital | 167 | -159 | 434 | - | - |